相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
Lars Wallentin et al.
PLOS MEDICINE (2021)
Significance of serum FGF-23 for risk assessment of contrast-associated acute kidney injury and clinical outcomes in patients undergoing coronary angiography
Shao-Sung Huang et al.
PLOS ONE (2021)
Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers
Kai M. Eggers et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
Phosphate-sensing and regulatory mechanism of FGF23 production
Y. Takashi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
A review on coronary artery disease, its risk factors, and therapeutics
Arup Kr. Malakar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Regulation of fibroblast growth factor 23 (FGF23) in health and disease
Ludmilla Baer et al.
FEBS LETTERS (2019)
Biomarkers in stable coronary artery disease
Cian P. McCarthy et al.
AMERICAN HEART JOURNAL (2018)
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
Amarnath Marthi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome A Secondary Analysis of a Randomized Clinical Trial
Brian A. Bergmark et al.
JAMA CARDIOLOGY (2018)
The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome
Sanoj Chacko et al.
FUTURE SCIENCE OA (2018)
Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease
Cheng Xue et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
Martin Reindl et al.
HEART (2017)
Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies
Zhexue Qin et al.
ATHEROSCLEROSIS (2017)
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease
Jose Tunon et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Elevated fibroblast growth factor-23 and risk of cardiovascular disease or mortality in the general population: A meta-analysis
Menglin Jiang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
Peter Wohlfahrt et al.
JACC-HEART FAILURE (2015)
Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
Vincent M. Brandenburg et al.
ATHEROSCLEROSIS (2014)
Fibroblast growth factor 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies
Yunjun Xiao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
Jacob A. Udell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis
Jeffrey J. Hsu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
Jose Tunon et al.
PLOS ONE (2014)
Fibroblast growth factor 23
Edward R. Smith et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
Yunjun Xiao et al.
PLOS ONE (2013)
Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
Per-Anton Westerberg et al.
BMC NEPHROLOGY (2013)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Alessandro Liberati et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
分享论文
